ClinicalTrials.Veeva

Menu

Assessment of Potential Interactions Between Cocaine and Tolcapone - 1

National Institutes of Health (NIH) logo

National Institutes of Health (NIH)

Status and phase

Unknown
Phase 1

Conditions

Cocaine-Related Disorders

Treatments

Drug: Tolcapone

Study type

Interventional

Funder types

NIH

Identifiers

NCT00033059
NIDA-CTO-0003-1

Details and patient eligibility

About

The purpose of this study is to assess the potential interactions between intravenous (IV) cocaine and tolcapone.

Full description

Double-blind, inpatient study by screening responses to cocaine infusions of 20 and 40 mg i.v. subjects into 1 of 2 treatment groups to assess potential interactions between i.v. cocaine infusion and treatment with tolcapone.

Sex

All

Ages

18 to 45 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Volunteers dependent on cocaine and are non-treatment seeking; between 18-45 yrs of age; DSM-4 criteria for cocaine abuse or dependence

Exclusion criteria

Additional criteria available during screening at the site

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems